C1Add image
CJC-1295 DAC + Ipamorelin Stack
PerformanceStackComponents: CJC-1295 DAC, Ipamorelin
A two-vial stack pairing long-acting CJC-1295 DAC (weekly) with daily Ipamorelin pulses.
Half-life
—
Common dose
100 – 2000 mcg
Dosing frequency
Daily
Administration
Subcutaneous
How it works
CJC-1295 DAC provides sustained GHRH-receptor activation; Ipamorelin adds clean, daily ghrelin-receptor pulses on top. The combination produces both baseline GH elevation and pulsatile peaks.
Protocol notes
Typical dosing: CJC-1295 DAC 1–2 mg once weekly + Ipamorelin 100–300 mcg daily. 8–16 week cycles.
Reported side effects
Combined profile: water retention, joint discomfort, injection-site reactions.